QBR110372

• Research type

  Research Study

• Full title

  An Open Label, Single-Dose, Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C] LC15-0444

• IRAS ID

  76598

• Contact name

  Stuart Mair

• Sponsor organisation

  LG Life Sciences

• Eudract number

  2011-000597-65

• Research summary

  LC15-0444 is an investigational drug that has not yet been approved in any country to treat any medical conditions. It is being investigated as a treatment for diabetes (disease in which a person has high blood sugar levels). The purpose of the study is to look at how LC15-0444 is taken up, broken down and removed by the body, when given by oral capsule. The study will also provide additional safety information on how the body responds to LC15-0444.

• REC name

  East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

• REC reference

  11/IE/0055

• Date of REC Opinion

  14 Apr 2011

• REC opinion

  Favourable Opinion